| Literature DB >> 35033192 |
Zhaoyue Men1,2, Meng Cao1, Yuechan Gong1, Lun Hua1, Ruihao Zhang1,2, Xin Zhu1,2, Lianchao Tang1, Xuemei Jiang1, Shengyu Xu1, Jian Li1, Lianqiang Che1, Yan Lin1, Bin Feng1, Zhengfeng Fang1, Yong Zhuo3.
Abstract
BACKGROUND: Dietary fiber (DF) is often eschewed in swine diet due to its anti-nutritional effects, but DF is attracting growing attention for its reproductive benefits. The objective of this study was to investigate the effects of DF intake level on oocyte maturation and uterine development, to determine the optimal DF intake for gilts, and gain microbial and metabolomic insight into the underlying mechanisms involved.Entities:
Keywords: Dietary fiber; Gilts; Metabolomics; Microbiota; Oocyte maturation
Year: 2022 PMID: 35033192 PMCID: PMC8760789 DOI: 10.1186/s40104-021-00657-0
Source DB: PubMed Journal: J Anim Sci Biotechnol ISSN: 1674-9782
Ingredients and nutrient compositions of basal diets (as fed basis), g/kg
| Ingredients, g/kg | Phases of experiment | |
|---|---|---|
| 1–60 d | 61 d–slaughter3 | |
| Corn | 720 | 780 |
| Soybean (44%CP) | 208 | 160 |
| Fish meal (65%CP) | 25 | 20 |
| Soybean oil | 20 | 17 |
| L-Lys HCl (98%) | 3 | 2 |
| DL-Met (99%) | 1 | 0.4 |
| L-Thr (98%) | 0.6 | 0.2 |
| L-Trp (98%) | 0.1 | 0 |
| Choline chloride (50%) | 1.5 | 1.5 |
| Sodium chloride (feed grade, > 99.0%) | 4 | 4 |
| Limestone | 6.2 | 5.9 |
| Monocalcium phosphate | 8.6 | 7 |
| Vitamin-mineral premix1 | 2 | 2 |
| Total | 1000 | 1000 |
| Nutrient composition, g/kg | ||
| Digestible energy, Mcal/kg | 3.4 | 3.4 |
| Crude protein | 169.1 | 147.2 |
| Total Lysine | 10.8 | 8.6 |
| SID Lysine | 9.8 | 7.8 |
| Calcium | 6.9 | 5.9 |
| Total phosphorus | 5.9 | 5.3 |
| Soluble fiber | 10.2 | 10.3 |
| Insoluble fiber | 115.0 | 113.9 |
| Total dietary fiber2 | 125.2 | 124.2 |
1Provided the following per kilogram of basal diet: 8000 IU vitamin A; 800 IU vitamin D3; 30 IU vitamin E; 4 mg vitamin K; 0.16 mg biotin; 2 mg folacin; 25 mg niacin; 20 mg pantothenic acid; 10 mg riboflavin; 2 mg thiamine; 1 mg vitamin B6; 20 μg vitamin B12; 16 mg copper as as copper sulfate; 0.25 mg iodine as potassium iodide; 125 mg iron as ferrous sulphate; 30 mg manganese as manganese sulfate; 0.25 mg selenium as sodium selenite; 125 mg zinc as zinc sulfate
2Total dietary fiber = soluble fiber + insoluble fiber, analyzed value according to method AOAC 991.43
3Gilts were slaughtered at the 19th day of 3rd estrous cycle
Fig. 1Schematic diagram of the experimental design. Two basal diets were formulated during 1 to 60 d and 61 d to the end of the experiment. Gilts were fed a basal diet, or a basal diet with three levels of extra dietary fiber (DF) during each phase. DF 1.0, basal diet without DF supplement, and DF 1.5, DF 1.75, and DF 2.0 were basal diets with an additional 50%, 75% and 100% DF, respectively. The DF mixture comprised inulin and cellulose at a ratio of 1:4
Effects of DF intake level on oocyte maturation in gilts
| Items | Treatments | |||||
|---|---|---|---|---|---|---|
| DF 1.0 | DF 1.5 | DF 1.75 | DF 2.0 | Linear | Quadratic | |
| No. of COCs collected per gilt | 23.3 ± 1.4 | 21.2 ± 1.2 | 22.2 ± 0.9 | 22.5 ± 2.3 | 0.695 | 0.403 |
| No. of oocytes for in vitro maturation | 15.5 ± 0.2 | 15.7 ± 0.2 | 15.7 ± 0.2 | 15.5 ± 0.2 | 0.898 | 0.467 |
| Expansion rate, % | 86.9 ± 5.9 | 89.5 ± 3.5 | 91.5 ± 2.1 | 93.6 ± 3.3 | 0.232 | 0.876 |
| Rate of oocytes with first polar body, % | 37.7 ± 3.2c | 41.6 ± 3.0bc | 57.5 ± 2.5a | 50.6 ± 2.3ab | 0.001 | 0.568 |
Data are expressed as means ± standard error (S.E.); DF, dietary fiber; n = 6; Means with different letters a,b,c denote P < 0.05
Fig. 2Effects of DF intake level on gene expression of COCs in gilts. GDF-9, Growth differentiation factor-9; BMP-15, Bone morphogenetic protein 15; DF 1.0, basal diet without DF supplement; DF 1.5, DF 1.75, and DF 2.0, basal diets with an additional 50, 75 and 100% DF intake, respectively. n = 6 per group. Columns with different letters a,b denote P < 0.05
Effects of DF intake level on the development of reproductive tracts in gilts
| Items | Treatments | |||||
|---|---|---|---|---|---|---|
| DF 1.0 | DF 1.5 | DF 1.75 | DF 2.0 | Linear | Quadratic | |
| BW at laughter, kg | 146.7 ± 1.6 | 145.3 ± 1.8 | 145.8 ± 3.0 | 142.3 ± 1.7 | 0.209 | 0.549 |
| Weight of uterus, kg | 0.80 ± 0.02 | 0.82 ± 0.02 | 0.90 ± 0.03 | 0.84 ± 0.02 | 0.059 | 0.380 |
| Relative weight of uterus, g/kg | 5.44 ± 0.17b | 5.64 ± 0.16ab | 6.21 ± 0.22a | 5.91 ± 0.14ab | 0.017 | 0.548 |
| Left uterine, cm | 99.2 ± 4.3b | 107.3 ± 3.3ab | 118.2 ± 5.3a | 109.2 ± 5.3ab | 0.044 | 0.232 |
| Right uterine, cm | 91.8 ± 4.2c | 99.3 ± 3.1bc | 121.7 ± 6.3a | 113.5 ± 6.0ab | 0.001 | 0.660 |
| Left oviduct, g | 3.93 ± 0.25 | 4.02 ± 0.47 | 5.19 ± 0.36 | 4.64 ± 0.50 | 0.087 | 0.880 |
| Right oviduct, g | 3.63 ± 0.22b | 4.12 ± 0.54b | 5.91 ± 0.30a | 4.97 ± 0.38ab | 0.002 | 0.446 |
| Left oviduct, cm | 30.5 ± 0.9 | 33.3 ± 2.6 | 35.3 ± 1.0 | 33.8 ± 1.7 | 0.100 | 0.400 |
| Right oviduct, cm | 30.6 ± 1.1 | 32.7 ± 2.5 | 36.5 ± 1.2 | 33.2 ± 2.1 | 0.123 | 0.343 |
Data are expressed as means ± S.E.; DF, dietary fiber; n = 6; Means with different letters a,b denote P < 0.05
Fig. 3Microbiota alpha-diversity in faeces of gilts fed different dietary fiber levels at 19 d of the 2nd oestrous cycle. a, Observed species. b, Shannon index. c, Chao 1 index. Gilts constituted the experimental units (n = 6). DF 1.0, basal diet without DF supplement; DF 1.5, DF 1.75 and DF 2.0, basal diets with an additional 50%, 75% and 100% DF intake, respectively. Columns with different letters a,b denote P < 0.05
Relative abundance of microbiota at the phyla level in faeces of gilts, %
| Items | Treatments | |||||
|---|---|---|---|---|---|---|
| 1.0 DF | 1.5 DF | 1.75DF | 2.0 DF | Linear | Quadratic | |
| Firmicutes | 44.22 ± 1.07ab | 47.63 ± 1.89a | 40.34 ± 1.53bc | 38.36 ± 0.80c | < 0.001 | 0.003 |
| Bacteroidetes | 40.64 ± 1.16bc | 38.81 ± 1.79c | 44.85 ± 1.78ab | 46.51 ± 1.42a | 0.004 | 0.043 |
| Spirochaetes | 4.62 ± 0.65ab | 3.29 ± 0.59b | 5.76 ± 0.63a | 5.60 ± 0.79ab | 0.169 | 0.079 |
| Proteobacteria | 4.08 ± 0.41a | 3.80 ± 0.26ab | 3.00 ± 0.23b | 3.00 ± 0.24b | 0.002 | 0.629 |
| Tenericutes | 2.12 ± 0.13 | 2.26 ± 0.27 | 2.73 ± 0.22 | 2.69 ± 0.16 | 0.013 | 0.866 |
| Euryarchaeota | 2.15 ± 0.32 | 2.72 ± 0.79 | 1.38 ± 0.38 | 1.97 ± 0.29 | 0.385 | 0.778 |
| Actinobacteria | 0.87 ± 0.55a | 0.22 ± 0.01b | 0.18 ± 0.02b | 0.23 ± 0.03b | < 0.001 | 0.008 |
| Lentisphaerae | 0.74 ± 0.05b | 0.67 ± 0.07b | 1.02 ± 0.08a | 0.82 ± 0.07ab | 0.062 | 0.840 |
| Planctomycetes | 0.13 ± 0.04ab | 0.26 ± 0.09a | 0.09 ± 0.02b | 0.05 ± 0.01b | 0.017 | 0.002 |
| Cyanobacteria | 0.17 ± 0.02bc | 0.15 ± 0.02c | 0.25 ± 0.04ab | 0.34 ± 0.05a | < 0.001 | 0.010 |
| Others | 0.25 ± 0.03b | 0.18 ± 0.01c | 0.41 ± 0.02a | 0.47 ± 0.05a | < 0.001 | < 0.001 |
Data are expressed as means ± S.E.; DF, dietary fiber; n = 6; Means with different letters a,b denote P < 0.05
Relative abundance of the top 53 microbiota at the genus level1,%
| Items | Treatments | |||||
|---|---|---|---|---|---|---|
| 1.0 DF | 1.5 DF | 1.75 DF | 2.0 DF | Linear | Quadratic | |
| 6.33 ± 0.37 | 6.70 ± 0.80 | 6.34 ± 0.65 | 7.10 ± 1.04 | 0.440 | 0.895 | |
| 2.21 ± 0.16c | 2.60 ± 0.46bc | 4.98 ± 1.10a | 3.81 ± 0.32ab | < 0.001 | 0.660 | |
| 3.46 ± 0.54ab | 2.52 ± 0.30b | 4.77 ± 0.73a | 5.14 ± 0.92a | 0.025 | 0.034 | |
| 4.23 ± 0.63 | 2.98 ± 0.57 | 4.94 ± 0.58 | 4.78 ± 0.79 | 0.368 | 0.119 | |
| 4.33 ± 0.31bc | 3.95 ± 0.33c | 5.61 ± 0.34ab | 5.80 ± 0.40a | 0.001 | 0.045 | |
| 3.83 ± 0.28b | 5.90 ± 0.56a | 3.50 ± 0.50b | 2.87 ± 0.29b | 0.027 | < 0.001 | |
| 2.05 ± 0.32 | 2.66 ± 0.79 | 1.34 ± 0.38 | 1.89 ± 0.28 | 0.413 | 0.726 | |
| 2.61 ± 0.27 | 3.16 ± 0.37 | 2.17 ± 0.23 | 2.15 ± 0.21 | 0.069 | 0.079 | |
| 2.46 ± 0.29a | 2.68 ± 0.16a | 1.85 ± 0.10b | 1.49 ± 0.11b | < 0.001 | 0.001 | |
| 2.32 ± 0.26 | 2.24 ± 0.26 | 2.27 ± 0.24 | 2.15 ± 0.18 | 0.620 | 0.895 | |
| 1.98 ± 0.30a | 1.61 ± 0.17ab | 1.00 ± 0.12c | 1.11 ± 0.15bc | < 0.001 | 0.845 | |
| 1.88 ± 0.36 | 1.85 ± 0.69 | 0.87 ± 0.17 | 1.30 ± 0.50 | 0.089 | 0.838 | |
| 2.42 ± 0.21 | 2.36 ± 0.21 | 2.30 ± 0.12 | 2.46 ± 0.24 | 0.989 | 0.571 | |
| 2.06 ± 0.08a | 2.42 ± 0.22a | 1.58 ± 0.15b | 1.51 ± 0.08b | 0.001 | 0.001 | |
| 1.54 ± 0.37 | 1.24 ± 0.22 | 1.27 ± 0.34 | 1.67 ± 0.38 | 0.934 | 0.212 | |
| 1.43 ± 0.08ab | 1.50 ± 0.12a | 1.18 ± 0.10b | 1.16 ± 0.06b | 0.008 | 0.169 | |
| 1.42 ± 0.08 | 1.32 ± 0.09 | 1.42 ± 0.14 | 1.41 ± 0.07 | 0.944 | 0.532 | |
| 1.36 ± 0.14 | 1.31 ± 0.12 | 1.12 ± 0.12 | 1.18 ± 0.11 | 0.149 | 0.922 | |
| 1.34 ± 0.13 | 1.28 ± 0.24 | 1.69 ± 0.14 | 1.92 ± 0.20 | 0.027 | 0.188 | |
| 1.28 ± 0.09bc | 1.25 ± 0.20c | 1.97 ± 0.15a | 1.88 ± 0.17ab | 0.002 | 0.382 | |
| 1.12 ± 0.11 | 1.13 ± 0.08 | 0.94 ± 0.08 | 0.85 ± 0.06 | 0.011 | 0.191 | |
| 1.00 ± 0.09 | 0.77 ± 0.10 | 0.79 ± 0.14 | 0.96 ± 0.14 | 0.680 | 0.095 | |
| 0.98 ± 0.08 | 1.03 ± 0.16 | 0.82 ± 0.09 | 0.88 ± 0.10 | 0.271 | 0.710 | |
| 0.87 ± 0.09a | 1.10 ± 0.16a | 0.60 ± 0.06b | 0.57 ± 0.03b | < 0.001 | 0.010 | |
| 0.81 ± 0.08 | 0.66 ± 0.10 | 1.01 ± 0.12 | 1.04 ± 0.09 | 0.055 | 0.080 | |
| 0.71 ± 0.04 | 0.67 ± 0.08 | 0.76 ± 0.03 | 0.81 ± 0.05 | 0.147 | 0.256 | |
| 0.66 ± 0.13 | 0.36 ± 0.06 | 0.78 ± 0.15 | 0.89 ± 0.21 | 0.154 | 0.010 | |
| 0.60 ± 0.06 | 0.68 ± 0.06 | 0.50 ± 0.04 | 0.52 ± 0.04 | 0.093 | 0.168 | |
| 0.56 ± 0.22a | 0.37 ± 0.09ab | 0.15 ± 0.02c | 0.23 ± 0.05bc | < 0.001 | 0.304 | |
| 0.52 ± 0.08 | 0.52 ± 0.07 | 0.68 ± 0.06 | 0.82 ± 0.12 | 0.008 | 0.179 | |
| 0.50 ± 0.03a | 0.48 ± 0.05ab | 0.39 ± 0.02b | 0.43 ± 0.02ab | 0.018 | 0.734 | |
| 0.53 ± 0.05 | 0.52 ± 0.04 | 0.67 ± 0.08 | 0.53 ± 0.04 | 0.541 | 0.492 | |
| 0.39 ± 0.03b | 0.31 ± 0.03b | 0.76 ± 0.10a | 0.79 ± 0.04a | < 0.001 | 0.001 | |
| 0.33 ± 0.06a | 0.33 ± 0.02a | 0.23 ± 0.02ab | 0.21 ± 0.02b | 0.001 | 0.212 | |
| 0.34 ± 0.02a | 0.29 ± 0.01a | 0.18 ± 0.02b | 0.19 ± 0.01b | < 0.001 | 0.764 | |
| 0.23 ± 0.04b | 0.21 ± 0.08b | 0.68 ± 0.27a | 0.51 ± 0.08ab | 0.002 | 0.534 | |
| 0.25 ± 0.04 | 0.28 ± 0.09 | 0.33 ± 0.13 | 0.25 ± 0.04 | 0.794 | 0.368 | |
| 0.22 ± 0.01a | 0.25 ± 0.03a | 0.13 ± 0.01b | 0.16 ± 0.01b | < 0.001 | 0.207 | |
| 0.20 ± 0.03a | 0.19 ± 0.01b | 0.14 ± 0.01b | 0.14 ± 0.01b | < 0.001 | 0.404 | |
| 0.21 ± 0.11a | 0.10 ± 0.01ab | 0.09 ± 0.02b | 0.07 ± 0.01b | < 0.001 | 0.526 | |
| 0.18 ± 0.05a | 0.17 ± 0.08a | 0.04 ± 0.01b | 0.08 ± 0.03ab | 0.003 | 0.896 | |
| 0.16 ± 0.01 | 0.15 ± 0.02 | 0.18 ± 0.02 | 0.17 ± 0.01 | 0.444 | 0.511 | |
| 0.15 ± 0.03a | 0.14 ± 0.01a | 0.08 ± 0.01b | 0.08 ± 0.01b | < 0.001 | 0.366 | |
| 0.14 ± 0.02ab | 0.12 ± 0.01b | 0.18 ± 0.02ab | 0.19 ± 0.02a | 0.024 | 0.064 | |
| 0.14 ± 0.03a | 0.05 ± 0.01b | 0.19 ± 0.06a | 0.25 ± 0.06a | 0.019 | < 0.001 | |
| 0.13 ± 0.01 | 0.11 ± 0.01 | 0.09 ± 0.02 | 0.14 ± 0.03 | 0.904 | 0.107 | |
| 0.12 ± 0.05 | 0.08 ± 0.02 | 0.20 ± 0.07 | 0.21 ± 0.08 | 0.061 | 0.058 | |
| 0.12 ± 0.02 | 0.06 ± 0.01 | 0.18 ± 0.02 | 0.25 ± 0.05 | < 0.001 | < 0.001 | |
| 0.12 ± 0.02 | 0.12 ± 0.02 | 0.07 ± 0.01 | 0.06 ± 0.01 | < 0.001 | 0.075 | |
| 0.10 ± 0.01 | 0.20 ± 0.12 | 0.13 ± 0.01 | 0.12 ± 0.01 | 0.571 | 0.044 | |
| 0.10 ± 0.02 | 0.09 ± 0.02 | 0.12 ± 0.02 | 0.13 ± 0.03 | 0.178 | 0.457 | |
| 0.08 ± 0.01 | 0.11 ± 0.04 | 0.09 ± 0.02 | 0.10 ± 0.02 | 0.751 | 0.595 | |
| 0.08 ± 0.01bc | 0.07 ± 0.01c | 0.15 ± 0.02a | 0.12 ± 0.01ab | 0.004 | 0.475 | |
Data are expressed as means ± S.E.; DF, dietary fiber; n = 6; Means with different letters a,b denote P < 0.05
Fig. 4Principal component analysis of the metabolites identified in positive and negative ionisation modes. DF 1.0, basal diet without DF supplement; DF 1.5, DF 1.75 and DF 2.0, basal diets with an additional 50%, 75% and 100% DF intake, respectively. QC, quality control samples
Differentially abundant serum metabolites between DF 1.0 and DF 1.75 gilts identified in positive and negative ionisation modes1,2
| Name | Fold change | Name | Fold change | ||
|---|---|---|---|---|---|
| Positive ionisation | Negative ionisation | ||||
(2S)-1-Hydroxy-3-(pentadecanoyloxy)- 2-propanyl (15Z)-15-tetracosenoate | 18.966 | 0.047 | Sinapyl alcohol | 27.041 | 0.044 |
3-(2,4-Cyclopentadien-1-ylidene)- 5alpha-androstan-17beta-ol | 5.594 | 0.003 | Cuauhtemone | 13.210 | < 0.001 |
| Oxandrolone | 5.563 | 0.013 | Cholic acid glucuronide | 8.250 | 0.025 |
| 2,6-Di-tert-butyl-1,4-benzoquinone | 5.028 | 0.005 | GLIMEPIRIDE, CIS- | 5.853 | < 0.001 |
| 19-Nortestosterone | 4.993 | 0.007 | Olivoretin D | 5.543 | 0.013 |
| 3-Beta-fluoro-5-beta-pregnan-20-one | 4.670 | 0.002 | Deoxycholic acid | 4.117 | 0.001 |
| p-Cymene | 4.148 | 0.008 | Avasimibe | 3.204 | 0.026 |
| Geroquinol | 3.979 | 0.006 | Taurochenodeoxycholic acid | 3.100 | 0.044 |
| Hypaphorine | 3.902 | < 0.001 | p-Dimethylinamyl benzoate | 3.077 | < 0.001 |
| Jasmonal | 3.766 | 0.007 | Chaksine | 3.026 | 0.003 |
| Ibuprofen | 3.680 | 0.002 | Tenivastatin | 2.962 | 0.009 |
| 3-Beta,17-beta-diacetoxy-5α-androstane | 3.057 | 0.007 | Mupirocin | 2.918 | 0.047 |
| Oleandomycin 2′-O-phosphate | 2.998 | 0.041 | Ubiquinone Q4 | 2.219 | 0.025 |
| Ionene | 2.869 | 0.049 | Sunitinib | 2.185 | 0.011 |
| Diaziquone | 2.858 | < 0.001 | (3alpha)-3-Hydroxycholan-24-oic acid | 2.054 | 0.042 |
| 1-Piperideine | 2.857 | 0.004 | Ifetroban | 2.038 | 0.010 |
| Myxalamid A | 2.801 | 0.045 | Maleimide | 1.918 | 0.012 |
| Genistein | 2.584 | 0.011 | 5-HT | 1.855 | 0.003 |
| 7-Ketodeoxycholic acid | 2.434 | 0.023 | Uldazepam | 1.814 | 0.018 |
1-O-[4-(1H-indol-3-yl)butanoyl] -beta-D-glucopyranose | 2.335 | 0.001 | Indole-3-carboxilic acid-O-sulphate | 1.690 | 0.019 |
| Linagliptin | 2.278 | 0.017 | 6α-Prostaglandin I1 | 0.566 | 0.011 |
| (KDO)2-lipid IVA | 2.096 | 0.045 | 3-Hydroxydecanoic acid | 0.548 | 0.021 |
| 4-Aminobenzoic acid | 2.089 | 0.043 | 14,18-Dihydroxy-12-oxo-9,13,15-octadecatrienoic acid | 0.542 | < 0.001 |
| Spermidine | 1.964 | 0.026 | Cromoglicic acid | 0.531 | < 0.001 |
| Hexoprenaline | 1.902 | 0.005 | Nemonapride (JAN) | 0.526 | 0.044 |
| Manumycin | 1.899 | 0.041 | Epithienamycin F | 0.519 | 0.010 |
| N-Lactoyl ethanolamine phosphate | 1.888 | 0.002 | 10-Undecenoic acid | 0.508 | 0.010 |
| Perphenazine enantate | 1.862 | 0.003 | Prunin | 0.502 | 0.010 |
| 5-HIAA | 1.856 | 0.002 | Leucodelphinidin | 0.497 | 0.001 |
| TU4153400 | 1.831 | 0.036 | MFCD00065806 | 0.496 | 0.015 |
1-Octadecanoyl-2-[(15Z)- tetracosenoyl]-sn-glycero-3-phosphocholine | 1.855 | 0.044 | 4,6,8-Trihydroxy-7-methoxy-3-methyl-3,4-dihydroisochromen-1-one | 0.494 | 0.029 |
| Bikhaconitine | 1.850 | 0.007 | ARAMITE | 0.485 | 0.024 |
| Cediranib | 1.797 | 0.002 | Uridine | 0.480 | 0.013 |
| Callystatin A | 1.782 | 0.017 | N-Palmitoyl-L-phenylalanine | 0.463 | 0.014 |
| Decoside | 1.690 | 0.005 | Cidofovir anhydrous | 0.460 | 0.004 |
5-methyltetrahydropteroyltri- L-Glutamic acid | 1.677 | 0.012 | 3-Indoxyl sulphate | 0.448 | 0.002 |
2-(2-Carboxyethyl)-4-methyl- 5-Pentyl-3-furoic acid | 1.640 | 0.012 | Butoctamide semisuccinate | 0.447 | 0.009 |
| Trans-Anethole | 1.637 | 0.021 | Kukoamine A | 0.443 | 0.001 |
| Saccharocin | 1.541 | 0.002 | Pyrophosphoric Acid | 0.433 | 0.033 |
| 5-Phospho-beta-D-ribosylamine | 1.540 | 0.009 | 4-Phenolsulfonic acid | 0.429 | 0.046 |
| Dehydrocholic acid | 1.50 | 0.013 | Geranyl phosphate | 0.412 | 0.043 |
| Tritoqualine | 0.634 | 0.008 | Caftaric acid | 0.412 | 0.008 |
| Benzoyl cyanide | 0.628 | < 0.001 | Disulfaton | 0.396 | 0.023 |
| Ocaperidone | 0.622 | 0.012 | 4-(1,2-Dihydroxy-2-propanyl)-1-methyl-1,2-cyclohexanediol | 0.388 | 0.021 |
| Monomethyl phosphate | 0.621 | 0.002 | Hydrogen bromide | 0.363 | < 0.001 |
| MFCD00056202 | 0.619 | 0.019 | (2-Hydroxy-2-oxido-1,3,2-dioxaphospholan-4-yl) methyl palmitate | 0.316 | 0.004 |
| Minosaminomycin | 0.589 | 0.037 | Chloralodol | 0.228 | < 0.001 |
| Trametinib | 0.557 | 0.003 | Caprylic acid | 0.199 | 0.024 |
| Premithramycin A3’ | 0.550 | 0.004 | 1,3-Nonanediol acetate | 0.187 | 0.039 |
| Alpha,alpha’-trehalose 6-mycolate | 0.546 | 0.005 | Retosiban | 0.170 | < 0.001 |
1-stearoyl-2-arachidonoyl- sn-glycero-3-phosphoserine | 0.521 | 0.033 | 3-Hydroxytridecanoic acid | 0.155 | 0.009 |
| Phytosphingosine | 0.521 | 0.016 | Difluprednate | 0.126 | < 0.001 |
| Depe | 0.484 | 0.006 | Leukotriene B4 | 0.075 | < 0.001 |
| Azithromycin | 0.462 | 0.001 | Pentachlorophenol | 0.071 | < 0.001 |
1-Stearoyl-2-docosahexanoyl- sn-glycero-3-phosphocholine | 0.461 | 0.037 | 3,4,15-Triacetoxy-12,13-epoxytrichothec-9-en-8-yl 3-methylbutanoate | 0.055 | < 0.001 |
| Benzyl succinate | 0.458 | 0.003 | Nobiletin | 0.029 | < 0.001 |
| Ascidiacyclamide | 0.457 | 0.005 | |||
1,2-Dioleoyl-sn-glycero-3-phospho- N,N-dimethylethanolamine | 0.436 | 0.011 | |||
| 12-Deoxyoligomycin A | 0.433 | 0.011 | |||
| Terminalin | 0.420 | 0.036 | |||
| Digitoxin | 0.415 | 0.028 | |||
| Uroporphyrinogen IV | 0.362 | 0.009 | |||
| Vilazodone | 0.361 | 0.001 | |||
N,N-Bis(2-hydroxyethyl) dodecanamide | 0.334 | 0.002 | |||
1-Eicosyl-2-docosanoyl-sn-glycero-3- phosphocholine | 0.307 | 0.042 | |||
| Emblicanin A | 0.275 | 0.007 | |||
| Phytolaccoside B | 0.221 | 0.025 |
Serum samples collected on 19 d of the 2nd oestrous cycle. Metabolites with VIP > 1, P-value < 0.05, fold change ≥ 1.5 or fold change ≤ 0.65 were considered differential metabolites
Fig. 5KEGG pathway analysis of differential metabolites identified in positive and negative ionisation modes between DF 1.0 and DF 1.75 groups. DF 1.0, basal diet without DF supplement; DF 1.75, basal diet with an additional 75% DF intake. DF, dietary fiber
Effects of DF intake level on the concentrations (μmol/g) of short-chain fatty acids in faeces and colon chyme of gilts
| Items | Treatments | |||||
|---|---|---|---|---|---|---|
| 1.0 DF | 1.5 DF | 1.75 DF | 2.0 DF | Linear | Quadratic | |
| 1Faeces at 30 d of experiment | ||||||
| Acetate | 40.1 ± 2.6b | 41.5 ± 2.9b | 47.6 ± 1.7ab | 51.4 ± 2.7a | 0.002 | 0.231 |
| Propionate | 14.2 ± 1.6b | 15.5 ± 1.4ab | 19.2 ± 0.8a | 19.4 ± 1.1a | 0.003 | 0.709 |
| Butyrate | 8.4 ± 0.8 | 9.8 ± 1.2 | 11.4 ± 1.1 | 12.1 ± 0.7 | 0.010 | 0.843 |
| 2Chyme in colon at 19 d of the 2nd oestrous cycle | ||||||
| Acetate | 58.9 ± 2.9 | 56.8 ± 4.8 | 63.7 ± 3.0 | 62.6 ± 3.0 | 0.324 | 0.604 |
| Propionate | 25.8 ± 1.1 | 24.8 ± 1.9 | 29.8 ± 1.2 | 31.8 ± 3.5 | 0.046 | 0.218 |
| Butyrate | 11.6 ± 0.4b | 12.5 ± 1.3ab | 13.1 ± 0.8ab | 15.4 ± 1.0a | 0.012 | 0.263 |
Faeces tested at 30 d of the experiment, n = 8; Chyme colon data, n = 6; Data are expressed as means ± S.E.; DF, dietary fiber; Means with different letters a,b denote P < 0.05
Effects of dietary fiber intake level on serotonin concentration in serum, follicular fluid and colon tissues of gilts
| Treatments | ||||||
|---|---|---|---|---|---|---|
| 1.0 DF | 1.5 DF | 1.75 DF | 2.0 DF | Linear | Quadratic | |
| At 30 d of experiment | ||||||
| Serum, ng/mL | 1422.1 ± 86.6b | 1713.4 ± 1115.3ab | 2069.1 ± 133.8a | 1879.5 ± 105.5a | 0.001 | 0.226 |
| FF, pg/mL | 209.8 ± 16.0 | 259.9 ± 24.9 | 286.1 ± 16.8 | 304.5 ± 32.1 | < 0.001 | 0.356 |
| At 19 d of the 2rd oestrous cycle | ||||||
| Serum, ng/mL | 646.8 ± 42.4c | 847.3 ± 32.2b | 1026.8 ± 68.5ab | 1141.0 ± 51.9a | < 0.001 | 0.598 |
| FF, pg/mL | 112.7 ± 10.0 | 124.8 ± 27.8 | 179.6 ± 35.8 | 180.1 ± 13.1 | 0.032 | 0.724 |
| Colons, ng/mg | 2.84 ± 0.28b | 3.05 ± 0.24b | 4.58 ± 0.20a | 4.11 ± 0.09a | < 0.001 | 0.928 |
Data are expressed as means ± S.E.; means with different letters a,b denote P < 0.05. DF, dietary fiber; FF, follicular fluid; n = 6
Linear regression between butyric acid (x, μmol/g) and serotonin in different tissues1
| Items | b0 | b1 | R2 | |
|---|---|---|---|---|
| Serotonin | ||||
| Serum, ng/mL | 24.705 | 67.739 | 0.624 | < 0.001 |
| Follicular fluid, pg/mL | −118.494 | 20.362 | 0.697 | < 0.001 |
| Colon, ng/mg | 1.266 | 0.181 | 0.281 | 0.008 |
1The linear regression model is y = b + b × x, where b0 denotes serum serotonin concentrations when the butyrate concentration in colonic content was 0 μmol/g, and b1 denotes the serotonin increment when the colonic butyrate content was increased to 1 μmol/g